0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.48%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-23.42%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-78.76%
Negative EBIT growth while 0376.HK is at 459.59%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-78.76%
Negative operating income growth while 0376.HK is at 1053.76%. Joel Greenblatt would press for urgent turnaround measures.
-98.53%
Negative net income growth while 0376.HK stands at 338.65%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-98.40%
Negative EPS growth while 0376.HK is at 340.27%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-98.40%
Negative diluted EPS growth while 0376.HK is at 340.27%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.03%
Slight or no buybacks while 0376.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.00%
Slight or no buyback while 0376.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
457531.89%
Dividend growth of 457531.89% while 0376.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
40.99%
Similar OCF growth to 0376.HK's 41.65%. Walter Schloss would assume comparable operations or industry factors.
40.27%
FCF growth 75-90% of 0376.HK's 46.66%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
-67.49%
Negative 10Y revenue/share CAGR while 0376.HK stands at 943.66%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-15.33%
Negative 5Y CAGR while 0376.HK stands at 2585.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.41%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-1697.85%
Negative 10Y OCF/share CAGR while 0376.HK stands at 940.11%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-72.92%
Negative 5Y OCF/share CAGR while 0376.HK is at 1480.60%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.00%
3Y OCF/share CAGR under 50% of 0376.HK's 90.01%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-98.53%
Negative 10Y net income/share CAGR while 0376.HK is at 130.22%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-96.55%
Negative 5Y net income/share CAGR while 0376.HK is 144.75%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
100.61%
3Y net income/share CAGR above 1.5x 0376.HK's 5.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
38.18%
Below 50% of 0376.HK's 462.19%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
39.20%
5Y equity/share CAGR at 50-75% of 0376.HK's 68.73%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
20.11%
Positive short-term equity growth while 0376.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
-19.39%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-55.55%
Negative 5Y dividend/share CAGR while 0376.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Firm’s AR is declining while 0376.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-10.88%
Inventory is declining while 0376.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.46%
Positive asset growth while 0376.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.69%
Under 50% of 0376.HK's 10.98%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.75%
We’re deleveraging while 0376.HK stands at 0.66%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.46%
Our R&D shrinks while 0376.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-13.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.